OMER Net Income Growth
Period ending:
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
OMER net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 65 observations from Jun 30, 2010 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| 201.9204% | |
| 156.2868% | |
| 97.8637% | |
| 9.9357% | |
| 12.5454% | |
| -26.2127% | |
| -33.105% | |
| -773.0288% | |
| -447.6565% | |
| -359.5844% | |
| -348.4615% | |
| -89.9711% | |
| -79.2423% | |
| -76.1978% | |
| -75.5878% | |
| 261.1731% | |
| 239.1905% | |
| 236.2157% | |
| 240.6878% | |
| 4.8872% | |
| -29.0761% | |
| -61.6202% | |
| -63.4129% | |
| -65.0016% | |
| -6.099% | |
| 26.3327% | |
| 33.3475% | |
| 34.2131% | |
| -15.9723% | |
| -76.8504% | |
| -137.0113% | |
| -111.7552% | |
| -39.2453% | |
| -11.6665% | |
| 19.8726% | |
| 15.5022% | |
| 13.5203% | |
| 20.3609% | |
| 11.1204% | |
| 11.9027% | |
| 2.0043% | |
| -1.6724% | |
| -1.9315% | |
| -38.6425% | |
| -47.7497% | |
| -64.7479% | |
| -85.1266% | |
| -19.9628% | |
| -11.6586% | |
| -14.7635% | |
| -3.5168% | |
| -11.6692% | |
| -32.0497% | |
| -29.577% | |
| -34.6739% | |
| -59.9586% | |
| -28.2806% | |
| -6.0655% | |
| 2.4102% | |
| 7.34% | |
| -11.0838% | |
| -30.8245% | |
| -38.7026% | |
| -26.0941% | |
| 5.4863% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All OMER financial metrics · OMER stock overview · How to interpret financial metrics